• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 85 pages
Exam (elaborations)

Nightingale Bsn 315 Pharmacology Ii New Hesi Exam – Questions With Answers & Rationales (Latest 2026/2027) Instant Pdf Download

Document preview thumbnail
Preview 4 out of 85 pages

NIGHTINGALE BSN 315 PHARMACOLOGY II NEW HESI EXAM – QUESTIONS WITH ANSWERS & RATIONALES (LATEST 2026/2027) INSTANT PDF DOWNLOAD

Content preview

NIGHTINGALE BSN 315
PHARMACOLOGY II NEW HESI EXAM
– QUESTIONS WITH ANSWERS &
RATIONALES (LATEST 2026/2027)
INSTANT PDF DOWNLOAD




Core Domains
1. Pharmacokinetics and Pharmacodynamics
2. Cardiovascular Pharmacology
3. Endocrine Pharmacology
4. Respiratory Pharmacology

,5. Neurological and Psychiatric Pharmacology
6. Anti-Infective and Antimicrobial Therapy
7. Pain Management and CNS Pharmacology
8. Medication Safety, Legal, and Ethical Standards
Introduction
This comprehensive examination is designed to assess the
advanced pharmacological knowledge and clinical decision-
making skills of baccalaureate nursing students preparing for the
HESI Pharmacology II specialty exam. The assessment evaluates
proficiency in pharmacokinetics, pharmacodynamics, drug
classifications, adverse effect recognition, patient safety
protocols, and therapeutic monitoring across the lifespan. The
multiple-choice and scenario-based questions emphasize real-
world application, critical thinking, and safe medication
administration practices essential for professional nursing
practice. Content aligns with the NCLEX-RN Pharmacological and
Parenteral Therapies domain and the HESI Pharmacology
blueprint, ensuring rigorous preparation for contemporary clinical
challenges.
SECTION ONE: QUESTIONS 1–100
1. A client is prescribed a medication with a half-life of 4
days. Based on this half-life, the medication will most
likely be prescribed:
A. Once a day
B. Twice a day
C. Three times a day
D. Four times a day

A. Once a day

, RATIONALE: Medications with long half-lives remain at
therapeutic levels between doses for extended periods, allowing
for once-daily dosing. A half-life of 4 days means the drug stays
in the body long enough that frequent dosing is unnecessary.
2. A client taking lisinopril reports swelling of the lips and
difficulty breathing. What is the nurse's priority action?
A. Administer the next dose with food
B. Hold the medication and notify the healthcare provider
immediately
C. Encourage increased fluid intake
D. Place the client in a supine position

B. Hold the medication and notify the healthcare provider
immediately

RATIONALE: Facial or lip swelling with breathing difficulty
suggests angioedema, a potentially life-threatening adverse
reaction associated with ACE inhibitors. The medication should be
withheld and emergency treatment initiated.
3. A patient is prescribed digoxin for heart failure. What is
the primary mechanism of action of digoxin?
A. Increases heart rate
B. Inhibits the sodium-potassium ATPase pump
C. Promotes vasodilation
D. Decreases contractility

B. Inhibits the sodium-potassium ATPase pump

RATIONALE: Digoxin inhibits the Na+/K+ ATPase pump,
increasing intracellular calcium and enhancing myocardial

, contractility. This positive inotropic effect improves cardiac output
in heart failure.
4. A nurse is administering a medication with a half-life of
4 hours. If the initial dose is 400 mg, what is the
approximate amount remaining after 8 hours?
A. 100 mg
B. 200 mg
C. 300 mg
D. 400 mg

A. 100 mg

RATIONALE: After 8 hours (2 half-lives): 400 mg → 200 mg (4
hrs) → 100 mg (8 hrs). Each half-life reduces the remaining drug
concentration by 50%.
5. A patient is taking warfarin. What is the primary
therapeutic effect of warfarin?
A. Increases platelet aggregation
B. Inhibits vitamin K-dependent clotting factors
C. Enhances fibrinolysis
D. Decreases prothrombin time

B. Inhibits vitamin K-dependent clotting factors

RATIONALE: Warfarin blocks factors II, VII, IX, and X,
prolonging PT/INR. This anticoagulant effect prevents clot
formation in conditions such as atrial fibrillation and venous
thromboembolism.
6. What is the primary route of elimination for most water-
soluble drugs?

Document information

Uploaded on
September 30, 2026
Number of pages
85
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$32.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
BestwriterGuru
4.8
(725)
Sold
254
Followers
34
Items
5490
Last sold
1 day ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these revision notes.

Didn't get what you expected? Choose another document

No problem! You can straightaway pick a different document that better suits what you're after.

Pay as you like, start learning straight away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and smashed it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions